Regeneron seeking more workers in Limerick for its Covid-19 response efforts

Regeneron aims to have hundreds of thousands of treatment doses ready for distribution this autumn

Based in the former Dell site in Raheen, Biopharmaceutical firm Regeneron wants more people to manufacture products for its REGN-COV2 anti-viral product.

The New York-headquartered company has signed a $450m (€395m) contract with the US government to produce thousands of doses of its REGN-COV2 anti-body cocktail to treat and prevent infection from Covid-19.

This is despite the fact that the drug has yet to complete clinical trials.